Thrombosis Drugs

A Global Strategic Business Report

MCP26637

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7512

EXECUTIVE POOL

5850

PRICE

823

EXPERT INPUTS

51

COMPANIES

306

DATA TABLES

387

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Thrombosis Drugs Market to Reach US$53.9 Billion by 2030

The global market for Thrombosis Drugs estimated at US$34.6 Billion in the year 2024, is expected to reach US$53.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Venous Thromboembolism, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$23.7 Billion by the end of the analysis period. Growth in the Deep Vein Thrombosis segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.3 Billion While China is Forecast to Grow at 12.3% CAGR

The Thrombosis Drugs market in the U.S. is estimated at US$9.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.2 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Thrombosis Drugs Market - Key Trends and Drivers Summarized

Thrombosis drugs are pharmaceutical agents used to prevent and treat thrombosis, which is the formation of a blood clot inside a blood vessel, potentially obstructing the flow of blood through the circulatory system. These drugs play a critical role in managing conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, which are significant causes of morbidity and mortality worldwide. The main classes of thrombosis drugs include anticoagulants like warfarin and newer direct oral anticoagulants (DOACs) such as dabigatran and rivaroxaban, antiplatelets like aspirin and clopidogrel, and thrombolytics used to dissolve clots. Anticoagulants work by interrupting the process that leads to clot formation, while antiplatelets prevent platelets from clumping together to form a clot, and thrombolytics help dissolve clots that have already formed. The choice of drug often depends on the specific thrombotic risk, patient factors, and the balance between reducing clotting risk and increasing the risk of bleeding, which is a common side effect of these medications.

The field of thrombosis drugs has seen significant advancements over the past few years, primarily driven by the development of DOACs, which offer several benefits over traditional warfarin therapy, including fewer dietary restrictions, reduced need for monitoring, and a lower risk of certain types of bleeding. These new agents have dramatically changed the landscape of anticoagulation therapy, providing more options and flexibility for both patients and healthcare providers. Furthermore, ongoing research continues to focus on developing safer, more effective thrombosis drugs with quicker onset actions and reversible effects to manage and mitigate the risks associated with emergency situations. Another important area of development is the personalization of thrombosis treatment based on genetic profiles, which can predict responses to certain drugs and help tailor treatments to individual needs, thereby maximizing efficacy and minimizing risks.

The growth in the thrombosis drugs market is driven by several factors, including an aging global population, increasing prevalence of cardiovascular diseases and conditions requiring thrombosis management, and technological advancements in drug development and personalization. The aging demographic is particularly prone to thrombotic events, which naturally increases the demand for effective thrombosis treatments. As cardiovascular conditions rise globally due to lifestyle factors and increased longevity, the need for effective clot management strategies becomes more critical. Furthermore, advancements in pharmacology and drug delivery systems, such as the development of targeted and timed-release drug formulations, enhance the effectiveness and user compliance of these treatments. The growing awareness of the risks associated with thrombosis and the availability of new treatment options have also encouraged more proactive management of potential thrombotic conditions. Lastly, healthcare systems are increasingly adopting guidelines that favor the early introduction and sustained use of thrombosis drugs in at-risk populations, supported by evidence-based practices. These trends collectively fuel the expansion of the thrombosis drugs market, reflecting ongoing efforts to improve patient outcomes in thrombosis management.

SCOPE OF STUDY

The report analyzes the Thrombosis Drugs market by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Other Disease Types); Drug Class (Anticoagulants, Antiplatelet Drugs, Thrombolytic Drugs); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Aspen Global Inc.; Bayer AG; Biogen, Inc.; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; CSL Ltd.; Daiichi Sankyo Co., Ltd.; Eugia US LLC; Grifols International SA; Italfarmaco SpA; LEO Pharma A/S; Merck & Co., Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi SA; Viatris;

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Global Economic Update

Thrombosis Drugs – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 86 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Thrombotic Disorders Drives Market Growth

Advances in Anticoagulant Therapy Propel Market Demand

Expansion of Cardiovascular Disease Management Spurs Market Adoption

Growing Awareness of Thrombosis and Its Complications Expands Addressable Market Opportunity

Rising Demand for Novel Oral Anticoagulants (NOACs) Drives Market Dynamics

Increasing Adoption in Hospital and Ambulatory Care Settings Propels Market Growth

Expansion of Health Insurance Coverage Strengthens Market Adoption

Growing Trend of Home-Based and Long-Term Care Bodes Well for Market Expansion

Increasing Availability of Generic and Biosimilar Drugs Strengthens Market Dynamics

Growth of the Aging Population Sets the Stage for Market Expansion

Increasing Use of Combination Therapies Generates New Opportunities

4. GLOBAL MARKET PERSPECTIVE

World Thrombosis Drugs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Thrombosis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Thrombosis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Thrombosis Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Venous Thromboembolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Venous Thromboembolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Venous Thromboembolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Pulmonary Embolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Anticoagulants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Antiplatelet Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Antiplatelet Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Antiplatelet Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Thrombolytic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Thrombolytic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Thrombolytic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

JAPAN

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

CHINA

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

EUROPE

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Thrombosis Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Thrombosis Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

FRANCE

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

GERMANY

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

UNITED KINGDOM

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Thrombosis Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

AUSTRALIA

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

INDIA

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

LATIN AMERICA

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Thrombosis Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Thrombosis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

MIDDLE EAST

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Thrombosis Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Thrombosis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

AFRICA

Thrombosis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Thrombosis Drugs by Disease Type - Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Thrombosis Drugs by Disease Type - Percentage Breakdown of Value Sales for Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism and Other Disease Types for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Thrombosis Drugs by Distribution Channel - Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Thrombosis Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Hospital Pharmacies and Retail Pharmacies for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Thrombosis Drugs by Drug Class - Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Thrombosis Drugs by Drug Class - Percentage Breakdown of Value Sales for Anticoagulants, Antiplatelet Drugs and Thrombolytic Drugs for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Aspen Global Inc.	%
Bayer AG	%
Biogen, Inc.	%
Boehringer Ingelheim International GmbH	%
Bristol-Myers Squibb Company	%
CSL Ltd.	%
Daiichi Sankyo Co., Ltd.	%
Eugia US LLC	%
Grifols International SA	%
Italfarmaco SpA	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll